Metraipolis › archive › dc_eab7cd5ec33f
Biophysical and biochemical studies support PHD inhibitor development as a TPI deficiency therapy — Europe PMC PMID:41949155
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41949155
- DOI
- 10.1242/jcs.264664
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T09:55:12.014Z
- SHA-256 of the archived text
8b5cb07177322d89c9647b5b2af20cc024043db613099fcd29506f6fb1bee7ac- Stable URL of this page
https://metraipolis.com/documento/dc_eab7cd5ec33f
How to cite
Biophysical and biochemical studies support PHD inhibitor development as a TPI deficiency therapy — Europe PMC PMID:41949155 — Europe PMC (en), https://europepmc.org/article/MED/41949155 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eab7cd5ec33f (Metraipolis archive dc_eab7cd5ec33f, sha256 8b5cb07177322d89c9647b5b2af20cc024043db613099fcd29506f6fb1bee7ac)
BibTeX
@misc{dceab7cd5ec33f,
title = {Biophysical and biochemical studies support PHD inhibitor development as a TPI deficiency therapy — Europe PMC PMID:41949155},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41949155},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eab7cd5ec33f; sha256 8b5cb07177322d89c9647b5b2af20cc024043db613099fcd29506f6fb1bee7ac},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41949155. Agents can read the archived copy with the MCP tool read_document.